中外製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2012/05/08 | 1,459 | 1,468 | 1,449 | 1,457 | +8 | +0.6% | 1,288,100 |
| 2012/05/07 | 1,427 | 1,455 | 1,417 | 1,449 | -8 | -0.5% | 1,003,100 |
| 2012/05/02 | 1,448 | 1,461 | 1,445 | 1,457 | +13 | +0.9% | 598,700 |
| 2012/05/01 | 1,445 | 1,462 | 1,440 | 1,444 | ±0 | ±0% | 757,200 |
| 2012/04/27 | 1,460 | 1,466 | 1,436 | 1,444 | -26 | -1.8% | 1,435,600 |
| 2012/04/26 | 1,473 | 1,474 | 1,449 | 1,470 | +4 | +0.3% | 1,042,500 |
| 2012/04/25 | 1,499 | 1,499 | 1,444 | 1,466 | +21 | +1.5% | 2,296,400 |
| 2012/04/24 | 1,444 | 1,464 | 1,438 | 1,445 | -10 | -0.7% | 1,446,700 |
| 2012/04/23 | 1,430 | 1,472 | 1,426 | 1,455 | +32 | +2.2% | 1,336,900 |
| 2012/04/20 | 1,420 | 1,429 | 1,417 | 1,423 | -12 | -0.8% | 1,064,500 |
| 2012/04/19 | 1,450 | 1,451 | 1,421 | 1,435 | -29 | -2% | 1,135,800 |
| 2012/04/18 | 1,456 | 1,468 | 1,447 | 1,464 | +8 | +0.5% | 1,073,700 |
| 2012/04/17 | 1,442 | 1,460 | 1,426 | 1,456 | +25 | +1.7% | 1,088,000 |
| 2012/04/16 | 1,412 | 1,449 | 1,409 | 1,431 | +6 | +0.4% | 830,900 |
| 2012/04/13 | 1,392 | 1,435 | 1,392 | 1,425 | +4 | +0.3% | 3,339,200 |
| 2012/04/12 | 1,432 | 1,437 | 1,417 | 1,421 | -17 | -1.2% | 992,600 |
| 2012/04/11 | 1,440 | 1,450 | 1,423 | 1,438 | -15 | -1% | 1,448,900 |
| 2012/04/10 | 1,449 | 1,467 | 1,440 | 1,453 | +1 | +0.1% | 1,111,100 |
| 2012/04/09 | 1,465 | 1,476 | 1,451 | 1,452 | -24 | -1.6% | 617,900 |
| 2012/04/06 | 1,467 | 1,483 | 1,464 | 1,476 | +7 | +0.5% | 687,500 |
| 2012/04/05 | 1,471 | 1,501 | 1,461 | 1,469 | -1 | -0.1% | 1,478,900 |
| 2012/04/04 | 1,476 | 1,504 | 1,467 | 1,470 | -5 | -0.3% | 1,222,700 |
| 2012/04/03 | 1,513 | 1,514 | 1,470 | 1,475 | -47 | -3.1% | 1,478,300 |
| 2012/04/02 | 1,527 | 1,538 | 1,517 | 1,522 | -4 | -0.3% | 1,442,700 |
| 2012/03/30 | 1,510 | 1,527 | 1,510 | 1,526 | +13 | +0.9% | 1,144,900 |
| 2012/03/29 | 1,498 | 1,515 | 1,490 | 1,513 | +6 | +0.4% | 830,700 |
| 2012/03/28 | 1,495 | 1,510 | 1,485 | 1,507 | +10 | +0.7% | 957,600 |
| 2012/03/27 | 1,488 | 1,500 | 1,484 | 1,497 | +29 | +2% | 1,195,000 |
| 2012/03/26 | 1,469 | 1,481 | 1,465 | 1,468 | -6 | -0.4% | 1,098,500 |
| 2012/03/23 | 1,438 | 1,486 | 1,438 | 1,474 | +27 | +1.9% | 1,511,200 |
| 2012/03/22 | 1,435 | 1,449 | 1,434 | 1,447 | +11 | +0.8% | 1,057,100 |
| 2012/03/21 | 1,436 | 1,439 | 1,426 | 1,436 | +2 | +0.1% | 894,800 |
| 2012/03/19 | 1,415 | 1,438 | 1,414 | 1,434 | +22 | +1.6% | 1,079,800 |
| 2012/03/16 | 1,415 | 1,419 | 1,407 | 1,412 | -4 | -0.3% | 681,900 |
| 2012/03/15 | 1,397 | 1,420 | 1,392 | 1,416 | +25 | +1.8% | 1,420,900 |
| 2012/03/14 | 1,410 | 1,410 | 1,391 | 1,391 | -4 | -0.3% | 1,100,300 |
| 2012/03/13 | 1,395 | 1,407 | 1,390 | 1,395 | +8 | +0.6% | 1,386,200 |
| 2012/03/12 | 1,398 | 1,399 | 1,383 | 1,387 | +4 | +0.3% | 890,300 |
| 2012/03/09 | 1,394 | 1,394 | 1,369 | 1,383 | +10 | +0.7% | 3,511,600 |
| 2012/03/08 | 1,374 | 1,381 | 1,362 | 1,373 | +11 | +0.8% | 832,800 |
| 2012/03/07 | 1,379 | 1,397 | 1,353 | 1,362 | -10 | -0.7% | 1,240,700 |
| 2012/03/06 | 1,341 | 1,376 | 1,341 | 1,372 | +16 | +1.2% | 1,917,300 |
| 2012/03/05 | 1,342 | 1,365 | 1,341 | 1,356 | +9 | +0.7% | 1,279,000 |
| 2012/03/02 | 1,330 | 1,349 | 1,327 | 1,347 | +17 | +1.3% | 869,200 |
| 2012/03/01 | 1,329 | 1,346 | 1,321 | 1,330 | ±0 | ±0% | 1,247,700 |
| 2012/02/29 | 1,315 | 1,357 | 1,314 | 1,330 | +13 | +1% | 2,088,200 |
| 2012/02/28 | 1,300 | 1,317 | 1,299 | 1,317 | +9 | +0.7% | 862,700 |
| 2012/02/27 | 1,299 | 1,312 | 1,286 | 1,308 | +20 | +1.6% | 1,219,700 |
| 2012/02/24 | 1,302 | 1,302 | 1,282 | 1,288 | -10 | -0.8% | 1,193,300 |
| 2012/02/23 | 1,290 | 1,299 | 1,286 | 1,298 | +16 | +1.2% | 1,447,500 |
3201～
3250
件表示中 / 3715件
類似銘柄と比較する
現在ご覧いただいている「中外薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 中外薬 | 761,900円 | +1.7% | +5.0% | 3.28% | 30.58倍 | 6.59倍 |
|
ロシュ傘下で成長続ける異色の医薬品大手。抗体・バイオで先行、抗がん剤、骨・関節領域に強い |
| 武 田 | 429,500円 | -1.1% | +75.3% | 4.66% | 29.42倍 | 0.97倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位１０強入り |
| 第一三共 | 348,500円 | +6.0% | +4.0% | 2.24% | 21.64倍 | 4.00倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
| 大塚ＨＤ | 677,800円 | +2.2% | +10.2% | 1.77% | 13.02倍 | 1.31倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界９０カ所に工場 |
| アステラス薬 | 139,600円 | +0.9% | +380.2% | 5.59% | 19.23倍 | 1.65倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
市場注目の銘柄
チャート関連のコラム
